Syncom Formulations (India) Limited (BOM:524470)

Market Cap	14.68B +1.0%
Revenue (ttm)	5.21B +11.9%
Net Income	764.38M +54.6%
EPS	0.81 +54.0%
Shares Out	940.00M
PE Ratio	19.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	554,619
Open	15.92
Previous Close	15.84
Day's Range	15.90 - 16.39
52-Week Range	10.21 - 23.46
Beta	0.76
Analysts	n/a
Price Target	n/a
Earnings Date	May 22, 2026

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, an...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 744
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524470

Financial Performance

In fiscal year 2026, BOM:524470's revenue was 5.21 billion, an increase of 11.93% compared to the previous year's 4.65 billion. Earnings were 764.38 million, an increase of 54.62%.